Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) Stock Falls 16% In a Month
The clinical stage biopharmaceutical company Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) has seen its stock go through a fairly rough time in recent weeks. Over the course of the past month, the stock has tanked by as much as 16% owing to a steady selloff. Trading Data On Monday, MTNB stock moved up 1.30% to $0.8864 with 649k shares, compared to its average volume of 1.22 million shares. The stock has…